The feasibility of assessing bowel cancer risk using genomic testing

Targeted screening in general practice

The National Bowel Cancer Screening Program (NBCSP) is currently being rolled out across Australia, eventually providing biennial FOBT to all Australians from age 50 to 74. However, uptake of the test is low at 37%. This study will look at the feasibility of performing SNP testing for colorectal cancer risk prediction within a GP setting, where the pre-test counselling is not as extensive as with traditional genetic testing.

Current status:

Open to recruitment